Dr. Ella Fung is the Co-Founder and CEO of Rosalind Dx, a venture-backed diagnostics company developing accessible prenatal testing to expand women's health access globally. She has led R&D and company-building across the US and Asia, with over 8 years of experience spanning biopharma and diagnostics. Prior to founding Rosalind Dx, she was an early employee at multiple life science startups, driving R&D strategy and innovation to advance solutions from lab to bedside. Earlier in her career, she was a Postdoctoral Fellow at Pfizer in Boston. Dr. Fung holds a PhD in Oncology from the University of Oxford, an MS in Genetics from Université Paris Diderot, and a BA (Hons) in Natural Sciences (Genetics) from the University of Cambridge.